Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | VHL |
Variant | W117* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | VHL W117* results in a premature truncation of the Vhl protein at amino acid 117 of 213 (UniProt.org). W117* has not been characterized, however, is associated with resistance to BET inhibitors in culture (PMID: 36329119) and due to the effects of other truncation mutations downstream of W117 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. |
Associated Drug Resistance | Y |
Category Variants Paths |
VHL mutant VHL inact mut VHL W117* |
Transcript | NM_000551.4 |
gDNA | chr3:g.10146523G>A |
cDNA | c.350G>A |
Protein | p.W117* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000551.4 | chr3:g.10146523G>A | c.350G>A | p.W117* | RefSeq | GRCh38/hg38 |
NM_000551.3 | chr3:g.10146523G>A | c.350G>A | p.W117* | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|